The objective of this study is to investigate the changes in CCNG1 and FDXR gene expression during RT in breast cancer patients and associate the observed changes with disease- and therapy-related confounding factors through a nonrandomized, controlled, open-trial clinical study of 57 breast cancer patients.
No takes yet. Share an insight, caveat, or question.
Eftimov Aleksandar (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: